Health Catalyst
HCAT
198 hedge funds and large institutions have $2.67B invested in Health Catalyst in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 97 increasing their positions, 50 reducing their positions, and 21 closing their positions.
322% more call options, than puts
Call options by funds: $15.4M | Put options by funds: $3.64M
94% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 50
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
0% more funds holding
Funds holding: 198 → 198 (0)
1% less capital invested
Capital invested by funds: $2.68B → $2.67B (-$13.7M)
3.38% less ownership
Funds ownership: 108.18% → 104.8% (-3.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$54.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$44.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$30M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$24.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$17.7M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15.2M |
| 3 |
RP
Regal Partners
Sydney, NSW,
Australia
|
-$9.12M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$6.8M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4.8M |
HCAT Hedge Fund Activity: Q3 2021 in Review
198 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q3 2021, worth a combined $2.67B — down 0.51% from $2.68B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new HCAT positions and 21 closed out — a net gain of 2 holders — while 97 added to existing stakes and 50 trimmed.
The largest buyer was Aberdeen Group, adding an estimated $54.1M. The largest seller was Massachusetts Financial Services, cutting an estimated $17.7M.
- 198 institutional investors held Health Catalyst (HCAT) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $2.67B of Health Catalyst stock for Q3 2021, down 0.51% quarter-over-quarter.
- 23 funds opened new Health Catalyst positions in Q3 2021 and 21 closed out, a net change of +2 holders.
- The largest Health Catalyst buyer in Q3 2021 was Aberdeen Group, an estimated $54.1M added.
- The largest Health Catalyst seller in Q3 2021 was Massachusetts Financial Services, an estimated $17.7M sold.
Based on aggregated 13F filings for Q3 2021.